Sleep apnea can be neurological, depending on the type. Most cases are obstructive sleep apnea (OSA), where soft tissue physically blocks the airway during sleep. But a less common form, central sleep apnea (CSA), is directly neurological: the brain temporarily stops sending signals to breathe. About 0.9% of the general population has central sleep apnea, making it far rarer than obstructive sleep apnea, which affects roughly 48% of people with any sleep-disordered breathing. Even obstructive sleep apnea, though not caused by a neurological problem, can damage the brain over time.
How Central Sleep Apnea Works
Your breathing is controlled by a rhythm generator located in the brainstem, the structure connecting the brain to the spinal cord. This region continuously sends signals to your diaphragm and chest muscles telling them to expand and contract. In central sleep apnea, that signal falters or stops entirely during sleep. Your airway stays open, but your body simply doesn’t try to breathe for several seconds at a time.
This is fundamentally different from obstructive sleep apnea. In OSA, your brain sends the breathing signal just fine, but relaxed throat muscles or excess tissue block the air from getting through. In central sleep apnea, there’s no blockage. The problem is upstream, in the brain itself. A sleep study can distinguish between the two by measuring respiratory effort: in obstructive events, the chest and abdomen strain against a closed airway, while in central events, there’s no effort at all.
Neurological Conditions That Cause It
Central sleep apnea often appears alongside other neurological problems. Stroke is one of the most common triggers, particularly when it damages the brainstem or disrupts the nerve pathways that regulate breathing. Brain tumors and structural changes in the brainstem can have the same effect. Research using advanced brain imaging has found that people with central sleep apnea show significant microstructural damage in the brainstem, and the severity of that damage correlates with the severity of their breathing disruptions during sleep.
The damage isn’t limited to the brainstem alone. Imaging studies have also identified changes in the nerve fibers connecting the frontal lobes to the brainstem. These pathways appear to play a role in regulating breathing rhythm, and when they deteriorate, central apnea episodes become longer and more frequent. Heart failure is another major cause, though through a different route: it creates a breathing pattern called Cheyne-Stokes respiration, where breathing gradually speeds up, slows down, and then stops in a repeating cycle throughout the night.
When CPAP Treatment Reveals a Hidden Problem
Some people are diagnosed with obstructive sleep apnea, start using a CPAP machine, and then develop central apneas they didn’t have before. This is called treatment-emergent central sleep apnea, and it highlights how neurological factors can lurk beneath what seems like a purely mechanical problem.
The likely explanation involves something called “loop gain,” a measure of how sensitive your breathing control system is. When CPAP opens the airway and improves airflow, carbon dioxide levels in the blood can drop below a critical threshold. In people with an oversensitive ventilatory control system, the brain interprets that drop as a signal to stop breathing. Other contributing factors include frequent arousals from sleep (which destabilize breathing patterns) and overinflation of the lungs by excessive CPAP pressure, which triggers stretch receptors that temporarily shut down the breathing signal.
How Obstructive Sleep Apnea Harms the Brain
Even standard obstructive sleep apnea, which isn’t caused by a neurological problem, creates one. Every time the airway collapses, oxygen levels in the blood drop. These repeated episodes of low oxygen trigger a cascade of harmful responses: inflammation, oxidative stress, high blood pressure, blood-brain barrier breakdown, and even brain swelling. Over time, this damages both white and gray matter in the brain.
The consequences are measurable. Severe OSA increases the risk of small-vessel disease in the brain and stroke. A postmortem study of 167 older adults found that those who had experienced more oxygen drops during sleep (measured on prior sleep studies) had more tiny areas of dead tissue, called microinfarcts, in their brains at autopsy. Brain imaging in younger and middle-aged adults with OSA shows unusual changes in white matter that suggest ongoing swelling or increased water content, signs the brain is actively responding to repeated oxygen deprivation rather than simply losing tissue.
These changes can affect thinking and memory. The combination of fragmented sleep and intermittent oxygen deprivation may reduce the brain’s ability to form new neurons, weaken connections between existing ones, and produce abnormal levels of proteins associated with Alzheimer’s disease. All of these pathways can contribute to cognitive decline and dementia with age.
How Neurological Sleep Apnea Is Treated
Standard CPAP, which works well for obstructive sleep apnea, is less reliable for central or complex sleep apnea. A more advanced device called adaptive servo-ventilation (ASV) monitors your breathing pattern in real time and adjusts air pressure breath by breath, filling in the gaps when your brain fails to send a breathing signal. In a controlled trial comparing the two approaches, about 90% of people using ASV achieved good control of their breathing disruptions at 90 days, compared to roughly 65% on standard CPAP.
For central sleep apnea caused by an underlying condition, treating that condition is the first priority. If a stroke or brain tumor is responsible, managing the neurological issue can sometimes improve the breathing pattern on its own. When heart failure is the driver, optimizing cardiac treatment often reduces or resolves the Cheyne-Stokes breathing pattern. In treatment-emergent cases, the central apneas resolve on their own in about one-third to two-thirds of people who continue using CPAP, though the remainder need a switch to ASV or another approach.
Telling the Types Apart
Central and obstructive sleep apnea share many surface-level symptoms: daytime sleepiness, waking up unrefreshed, difficulty concentrating, and disrupted sleep. The key differences are subtle and usually require a sleep study to confirm. People with central sleep apnea are more likely to wake up feeling short of breath rather than gasping or choking, and bed partners are less likely to notice loud snoring since the airway itself isn’t obstructed.
A sleep study distinguishes the two by tracking whether your body attempts to breathe during each pause. If sensors on your chest and abdomen detect effort against a closed airway, the event is obstructive. If they detect no effort at all, it’s central. Many people have a mix of both types, which is one reason a formal sleep study matters more than symptom checklists alone.